FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/10/037652 [Registered on: 28/10/2021] Trial Registered Prospectively
Last Modified On: 28/10/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Siddha 
Study Design  Single Arm Study 
Public Title of Study   A clinical trial to study the effect of the drug Suringiyathi Chooranam for the management of patients with Sinusitis( Azhal thalainokkadu) 
Scientific Title of Study   Phase II Non-randomized open clinical evaluation of siddha medicine Suringiyathi Chooranam for the management of Azhal Thalainokkadu (Sinusitis) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Jayasri J M 
Designation  PG Scholar 
Affiliation  Government Siddha Medical College Chennai 
Address  Post Graduate Department of General Medicine Government Siddha Medical College Arumbakkam Chennai TamilNadu India
Government Siddha Medical College Arumbakkam Chennai 600106 TamilNadu India
Chennai
TAMIL NADU
600106
India 
Phone  9843294118  
Fax    
Email  jayasrivishva84@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Chithra U 
Designation  Lecturer 
Affiliation  Government Siddha Medical College 
Address  Post Graduate Department of General Medicine Government Siddha Medical College Arumbakkam Chennai TamilNadu India
Post Graduate Department of General Medicine Government Siddha Medical College Arumbakkam Chennai 600106 TamilNadu India
Chennai
TAMIL NADU
600106
India 
Phone  9025006404  
Fax    
Email  mmsankar2000@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Chithra U 
Designation  Lecturer 
Affiliation  Government Siddha Medical College 
Address  Post Graduate Department of General Medicine Government Siddha Medical College Arumbakkam Chennai TamilNadu India
Post Graduate Department of General Medicine Government Siddha Medical College Arumbakkam Chennai 600106 TamilNadu India
Chennai
TAMIL NADU
600106
India 
Phone  9025006404  
Fax    
Email  mmsankar2000@gmail.com  
 
Source of Monetary or Material Support  
Government Siddha Medical College Anna arch road Arumbakkam Chennai 600106 TamilNadu 
 
Primary Sponsor  
Name  Government Siddha Medical College 
Address  Government Siddha Medical College Anna arch road Arumbakkam Chennai 600106 TamilNadu 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Jayasri J M  Aringar Anna Government Hospital of Indian Medicine  Room no 1 Siddha department of medicine 6 Anna arch road Arumbakkam Chennai 600106 TamilNadu
Chennai
TAMIL NADU 
9843294118

jayasrivishva84@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Commitee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J019||Acute sinusitis, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NIL  NIL 
Intervention  Suringiyathi Chooranam  2gms of Suringiyathi Chooranam idhu administered twice a day with hot water for 48 days 
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Rhinorrhoea
Headache
Pain and tenderness over para nasal sinus
Recurrent sneezing
Hyposmia or anosmia
Nasal congestion 
 
ExclusionCriteria 
Details  Pregnancy and lactation
Vasomotor rhinitis
Opthalmic headache
Migraine
Otitis media 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Primary outcome is mainly assessed by reduction of clinical symptoms after 48 days and also assessed by Adelaide symptoms severity score   Primary outcome is mainly assessed by reduction of clinical symptoms after 48 days and also assessed by Adelaide symptoms severity score 
 
Secondary Outcome  
Outcome  TimePoints 
Secondary outcome is mainly assessed by comparing the safety parameters before and after treatment  48days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   30/10/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a single non randomised open clinical trial to study the safety and efficacy of Suringiyathi Chooranam. The trial drug is given 2gms twice a day for 48days. The clinical trial is conducted after conducting pre clinical toxicity study. The trial drug Suringiyathi Chooranam is mentioned in Anuboga vaithiya Deva Ragasiyam.During the trial all the study related date will be recorded and documented. After the completion of trial all the data will be analysed statistically. 
Close